

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-serine metabolic process (GO:0006563) | 5.08610421 |
| 2 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.37580175 |
| 3 | alpha-linolenic acid metabolic process (GO:0036109) | 4.31722752 |
| 4 | low-density lipoprotein particle remodeling (GO:0034374) | 4.14425067 |
| 5 | very long-chain fatty acid metabolic process (GO:0000038) | 4.03463825 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.03067234 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 4.03067234 |
| 8 | serine family amino acid biosynthetic process (GO:0009070) | 4.01790561 |
| 9 | proline biosynthetic process (GO:0006561) | 3.98179121 |
| 10 | protein retention in ER lumen (GO:0006621) | 3.92428373 |
| 11 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.90766984 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.79510590 |
| 13 | L-phenylalanine metabolic process (GO:0006558) | 3.79510590 |
| 14 | doxorubicin metabolic process (GO:0044598) | 3.77726184 |
| 15 | daunorubicin metabolic process (GO:0044597) | 3.77726184 |
| 16 | polyketide metabolic process (GO:0030638) | 3.77726184 |
| 17 | mannose metabolic process (GO:0006013) | 3.73171547 |
| 18 | tricarboxylic acid cycle (GO:0006099) | 3.69541811 |
| 19 | barbed-end actin filament capping (GO:0051016) | 3.67963643 |
| 20 | cysteine metabolic process (GO:0006534) | 3.65259196 |
| 21 | purine ribonucleotide transport (GO:0015868) | 3.63987849 |
| 22 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.58037012 |
| 23 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.55932169 |
| 24 | negative regulation of cell size (GO:0045792) | 3.53479434 |
| 25 | cellular modified amino acid catabolic process (GO:0042219) | 3.51943679 |
| 26 | regulation of cholesterol metabolic process (GO:0090181) | 3.51024864 |
| 27 | adherens junction assembly (GO:0034333) | 3.50401328 |
| 28 | apoptotic process involved in morphogenesis (GO:0060561) | 3.48474467 |
| 29 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.47380465 |
| 30 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.47380465 |
| 31 | NADH dehydrogenase complex assembly (GO:0010257) | 3.47380465 |
| 32 | sulfur amino acid catabolic process (GO:0000098) | 3.46858722 |
| 33 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.45735521 |
| 34 | regulation of early endosome to late endosome transport (GO:2000641) | 3.44248952 |
| 35 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.43198472 |
| 36 | nucleotide transmembrane transport (GO:1901679) | 3.43155846 |
| 37 | focal adhesion assembly (GO:0048041) | 3.42839665 |
| 38 | cell-substrate adherens junction assembly (GO:0007045) | 3.42839665 |
| 39 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.41931102 |
| 40 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.39074242 |
| 41 | high-density lipoprotein particle remodeling (GO:0034375) | 3.37407081 |
| 42 | aspartate family amino acid catabolic process (GO:0009068) | 3.36085439 |
| 43 | protein localization to endosome (GO:0036010) | 3.35312117 |
| 44 | fatty acid elongation (GO:0030497) | 3.33009240 |
| 45 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.31836251 |
| 46 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.31630998 |
| 47 | reverse cholesterol transport (GO:0043691) | 3.30865884 |
| 48 | nucleotide transport (GO:0006862) | 3.25526707 |
| 49 | acyl-CoA biosynthetic process (GO:0071616) | 3.25041721 |
| 50 | thioester biosynthetic process (GO:0035384) | 3.25041721 |
| 51 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.24844331 |
| 52 | plasma lipoprotein particle remodeling (GO:0034369) | 3.23917582 |
| 53 | protein-lipid complex remodeling (GO:0034368) | 3.23917582 |
| 54 | macromolecular complex remodeling (GO:0034367) | 3.23917582 |
| 55 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.22241972 |
| 56 | heme transport (GO:0015886) | 3.21585219 |
| 57 | oxaloacetate metabolic process (GO:0006107) | 3.20662866 |
| 58 | regulation of extracellular matrix disassembly (GO:0010715) | 3.19167745 |
| 59 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 3.17005539 |
| 60 | purine nucleotide transport (GO:0015865) | 3.15263744 |
| 61 | L-methionine salvage (GO:0071267) | 3.14210928 |
| 62 | L-methionine biosynthetic process (GO:0071265) | 3.14210928 |
| 63 | amino acid salvage (GO:0043102) | 3.14210928 |
| 64 | NADH metabolic process (GO:0006734) | 3.13031813 |
| 65 | lysine catabolic process (GO:0006554) | 3.12232871 |
| 66 | lysine metabolic process (GO:0006553) | 3.12232871 |
| 67 | signal peptide processing (GO:0006465) | 3.11979463 |
| 68 | folic acid transport (GO:0015884) | 3.09660414 |
| 69 | homocysteine metabolic process (GO:0050667) | 3.09590443 |
| 70 | ethanol oxidation (GO:0006069) | 3.09452229 |
| 71 | fatty acid beta-oxidation (GO:0006635) | 3.08521581 |
| 72 | cellular ketone body metabolic process (GO:0046950) | 3.07073637 |
| 73 | basement membrane organization (GO:0071711) | 3.05891527 |
| 74 | UV protection (GO:0009650) | 3.03656697 |
| 75 | lipid oxidation (GO:0034440) | 3.03510026 |
| 76 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.03376509 |
| 77 | response to misfolded protein (GO:0051788) | 3.02389777 |
| 78 | bile acid biosynthetic process (GO:0006699) | 3.00744430 |
| 79 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.00518572 |
| 80 | negative regulation of response to reactive oxygen species (GO:1901032) | 3.00244590 |
| 81 | succinate metabolic process (GO:0006105) | 3.00075299 |
| 82 | stress fiber assembly (GO:0043149) | 2.99655088 |
| 83 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.99380568 |
| 84 | 2-oxoglutarate metabolic process (GO:0006103) | 2.98742818 |
| 85 | aggressive behavior (GO:0002118) | 2.97715818 |
| 86 | proline metabolic process (GO:0006560) | 2.95929119 |
| 87 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.95535202 |
| 88 | valine metabolic process (GO:0006573) | 2.92671039 |
| 89 | activation of Rac GTPase activity (GO:0032863) | 2.92145984 |
| 90 | semaphorin-plexin signaling pathway (GO:0071526) | 2.91719105 |
| 91 | cell-substrate junction assembly (GO:0007044) | 2.91235171 |
| 92 | purine nucleotide salvage (GO:0032261) | 2.89894343 |
| 93 | fatty acid oxidation (GO:0019395) | 2.89831317 |
| 94 | adenine nucleotide transport (GO:0051503) | 2.89419437 |
| 95 | carnitine metabolic process (GO:0009437) | 2.89269345 |
| 96 | tricarboxylic acid metabolic process (GO:0072350) | 2.88575774 |
| 97 | glucosamine-containing compound catabolic process (GO:1901072) | 2.86395802 |
| 98 | fatty acid catabolic process (GO:0009062) | 2.85916097 |
| 99 | branched-chain amino acid catabolic process (GO:0009083) | 2.85728995 |
| 100 | maternal placenta development (GO:0001893) | 2.84979053 |
| 101 | glyoxylate metabolic process (GO:0046487) | 2.83399964 |
| 102 | regulation of cholesterol esterification (GO:0010872) | 2.83111374 |
| 103 | monocarboxylic acid catabolic process (GO:0072329) | 2.79164727 |
| 104 | protein complex biogenesis (GO:0070271) | 2.79115344 |
| 105 | negative regulation of myotube differentiation (GO:0010832) | 2.77639138 |
| 106 | DNA deamination (GO:0045006) | 2.77592867 |
| 107 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.76939469 |
| 108 | L-serine transport (GO:0015825) | 2.76687831 |
| 109 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.76037905 |
| 110 | short-chain fatty acid metabolic process (GO:0046459) | 2.75751101 |
| 111 | regulation of cholesterol homeostasis (GO:2000188) | 2.74877695 |
| 112 | response to lead ion (GO:0010288) | 2.74628097 |
| 113 | purine-containing compound salvage (GO:0043101) | 2.74210550 |
| 114 | negative regulation of fatty acid transport (GO:2000192) | 2.74103724 |
| 115 | amino-acid betaine metabolic process (GO:0006577) | 2.72955758 |
| 116 | pentose-phosphate shunt (GO:0006098) | 2.72028219 |
| 117 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.71172355 |
| 118 | COPI coating of Golgi vesicle (GO:0048205) | 2.70252579 |
| 119 | Golgi transport vesicle coating (GO:0048200) | 2.70252579 |
| 120 | response to laminar fluid shear stress (GO:0034616) | 2.70228788 |
| 121 | acyl-CoA metabolic process (GO:0006637) | 2.69561456 |
| 122 | thioester metabolic process (GO:0035383) | 2.69561456 |
| 123 | cell-cell junction maintenance (GO:0045217) | 2.68316226 |
| 124 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.68186521 |
| 125 | cellular response to exogenous dsRNA (GO:0071360) | 2.68173514 |
| 126 | aromatic amino acid family catabolic process (GO:0009074) | 2.67751605 |
| 127 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.67745461 |
| 128 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.67080948 |
| 129 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.67038377 |
| 130 | peroxisome fission (GO:0016559) | 2.66682140 |
| 131 | carbohydrate derivative transport (GO:1901264) | 2.65560117 |
| 132 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.65532931 |
| 133 | glucose catabolic process (GO:0006007) | 2.65102432 |
| 134 | plasma lipoprotein particle organization (GO:0071827) | 2.63425359 |
| 135 | epithelial cell-cell adhesion (GO:0090136) | 2.63396318 |
| 136 | central nervous system myelination (GO:0022010) | 2.62950140 |
| 137 | axon ensheathment in central nervous system (GO:0032291) | 2.62950140 |
| 138 | positive regulation of receptor recycling (GO:0001921) | 2.62541272 |
| 139 | cholesterol biosynthetic process (GO:0006695) | 2.61384783 |
| 140 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.61128449 |
| 141 | NAD metabolic process (GO:0019674) | 2.59681620 |
| 142 | apoptotic cell clearance (GO:0043277) | 2.58724587 |
| 143 | modulation by symbiont of host cellular process (GO:0044068) | 2.55991993 |
| 144 | atrioventricular valve morphogenesis (GO:0003181) | 2.54636000 |
| 145 | adenosine receptor signaling pathway (GO:0001973) | 2.53857855 |
| 146 | pinocytosis (GO:0006907) | 2.53524622 |
| 147 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.51000340 |
| 148 | protein carboxylation (GO:0018214) | 2.50368405 |
| 149 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.50368405 |
| 150 | amyloid precursor protein catabolic process (GO:0042987) | 2.50091058 |
| 151 | protein targeting to plasma membrane (GO:0072661) | 2.49677564 |
| 152 | modulation by virus of host morphology or physiology (GO:0019048) | 2.46067005 |
| 153 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.45408323 |
| 154 | positive regulation of protein dephosphorylation (GO:0035307) | 2.45331466 |
| 155 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.43451189 |
| 156 | embryo implantation (GO:0007566) | 2.42095580 |
| 157 | activation of MAPKKK activity (GO:0000185) | 2.41443730 |
| 158 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.41137882 |
| 159 | regulation of ARF protein signal transduction (GO:0032012) | 2.40651154 |
| 160 | negative regulation of viral release from host cell (GO:1902187) | 2.39580603 |
| 161 | creatine metabolic process (GO:0006600) | 2.39471466 |
| 162 | modulation by virus of host process (GO:0019054) | 2.37976719 |
| 163 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.37602055 |
| 164 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.37358185 |
| 165 | apoptotic process involved in development (GO:1902742) | 2.32598021 |
| 166 | positive regulation of nuclease activity (GO:0032075) | 2.31354760 |
| 167 | cell volume homeostasis (GO:0006884) | 2.30909288 |
| 168 | GDP-mannose metabolic process (GO:0019673) | 2.30755985 |
| 169 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.30668884 |
| 170 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.30457316 |
| 171 | regulation of extracellular matrix organization (GO:1903053) | 2.29806686 |
| 172 | regulation of ARF GTPase activity (GO:0032312) | 2.29776740 |
| 173 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.28688354 |
| 174 | urea cycle (GO:0000050) | 2.27170537 |
| 175 | positive regulation of histone deacetylation (GO:0031065) | 2.26511472 |
| 176 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.25281971 |
| 177 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.24968056 |
| 178 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.24011304 |
| 179 | sodium ion export (GO:0071436) | 2.21794708 |
| 180 | negative regulation of catenin import into nucleus (GO:0035414) | 2.21362973 |
| 181 | glucose 6-phosphate metabolic process (GO:0051156) | 2.19623516 |
| 182 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.19377158 |
| 183 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.19162431 |
| 184 | adhesion of symbiont to host (GO:0044406) | 2.18787295 |
| 185 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.18716648 |
| 186 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.18272402 |
| 187 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.18225717 |
| 188 | low-density lipoprotein particle clearance (GO:0034383) | 2.16774088 |
| 189 | NADPH regeneration (GO:0006740) | 2.16383868 |
| 190 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.16198239 |
| 191 | activation of JUN kinase activity (GO:0007257) | 2.15846992 |
| 192 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.14137424 |
| 193 | amyloid precursor protein metabolic process (GO:0042982) | 2.12772620 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.44714404 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.19944499 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.42701709 |
| 4 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.33120823 |
| 5 | LXR_22292898_ChIP-Seq_THP-1_Human | 3.09847706 |
| 6 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 3.07196791 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.96109205 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.87769657 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.87402777 |
| 10 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.86569873 |
| 11 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.83046501 |
| 12 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.80933219 |
| 13 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.77766357 |
| 14 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.75441975 |
| 15 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.73151574 |
| 16 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.49142862 |
| 17 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.48032218 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.46035300 |
| 19 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.45471774 |
| 20 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.45075002 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 2.44467037 |
| 22 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.41572552 |
| 23 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.40121541 |
| 24 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.38034002 |
| 25 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.37266408 |
| 26 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.34923758 |
| 27 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.32504476 |
| 28 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.24686005 |
| 29 | MYC_22102868_ChIP-Seq_BL_Human | 2.23984864 |
| 30 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.09137733 |
| 31 | * HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.08306070 |
| 32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.07446511 |
| 33 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.02714985 |
| 34 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.99642119 |
| 35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98619294 |
| 36 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.93226498 |
| 37 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.90889944 |
| 38 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.89235820 |
| 39 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.88965586 |
| 40 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.86213499 |
| 41 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.81405213 |
| 42 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.80744874 |
| 43 | P68_20966046_ChIP-Seq_HELA_Human | 1.80476688 |
| 44 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.80308142 |
| 45 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.80059177 |
| 46 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.77124613 |
| 47 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.73237962 |
| 48 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73169714 |
| 49 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.72485174 |
| 50 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.71978448 |
| 51 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.69454852 |
| 52 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.66627926 |
| 53 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.65481937 |
| 54 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.64170672 |
| 55 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.64037824 |
| 56 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.62352552 |
| 57 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.61542443 |
| 58 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.58724327 |
| 59 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.57348442 |
| 60 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.53260824 |
| 61 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.52546816 |
| 62 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.52355829 |
| 63 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.50858461 |
| 64 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.49601000 |
| 65 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.49575690 |
| 66 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.48522150 |
| 67 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.48494826 |
| 68 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.46290258 |
| 69 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.45664424 |
| 70 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.44734275 |
| 71 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.44055774 |
| 72 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.43700948 |
| 73 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.43351313 |
| 74 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.43185748 |
| 75 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.41909730 |
| 76 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.41107924 |
| 77 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.40544999 |
| 78 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.40472681 |
| 79 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.38750782 |
| 80 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37992055 |
| 81 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.36986953 |
| 82 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36545107 |
| 83 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.36265036 |
| 84 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.35230323 |
| 85 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.34901609 |
| 86 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.34334285 |
| 87 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.33867872 |
| 88 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.31343009 |
| 89 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.31058163 |
| 90 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.30083562 |
| 91 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.29654026 |
| 92 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.26153247 |
| 93 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.25542658 |
| 94 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.25032804 |
| 95 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.24295897 |
| 96 | * MAF_26560356_Chip-Seq_TH2_Human | 1.23270105 |
| 97 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.22774806 |
| 98 | MAF_26560356_Chip-Seq_TH1_Human | 1.22669062 |
| 99 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.22421528 |
| 100 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.21291375 |
| 101 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.21126615 |
| 102 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.20549840 |
| 103 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.20166393 |
| 104 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18037403 |
| 105 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.17867330 |
| 106 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.17773066 |
| 107 | ATF3_27146783_Chip-Seq_COLON_Human | 1.16217033 |
| 108 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15940700 |
| 109 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15716999 |
| 110 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.15272583 |
| 111 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.13715503 |
| 112 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.12732080 |
| 113 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.12729568 |
| 114 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.12415704 |
| 115 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.11148069 |
| 116 | UTX_26944678_Chip-Seq_JUKART_Human | 1.10321613 |
| 117 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.09875783 |
| 118 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.09735416 |
| 119 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.09582395 |
| 120 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.09457204 |
| 121 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.09327818 |
| 122 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.09164117 |
| 123 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.08810997 |
| 124 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.08643187 |
| 125 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07848241 |
| 126 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.07723923 |
| 127 | AR_20517297_ChIP-Seq_VCAP_Human | 1.07241844 |
| 128 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.06699797 |
| 129 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.06649093 |
| 130 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.05610694 |
| 131 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.05607124 |
| 132 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.05422228 |
| 133 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.05204316 |
| 134 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.04453508 |
| 135 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.04235477 |
| 136 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.03812591 |
| 137 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.03255371 |
| 138 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.03130243 |
| 139 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.02350061 |
| 140 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.02330487 |
| 141 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.01598485 |
| 142 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.01440912 |
| 143 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.01440770 |
| 144 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.00629540 |
| 145 | SA1_27219007_Chip-Seq_Bcells_Human | 0.99751579 |
| 146 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.99348040 |
| 147 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.99281852 |
| 148 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.98852059 |
| 149 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.98084022 |
| 150 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.97659076 |
| 151 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97090011 |
| 152 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.96065072 |
| 153 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.95407920 |
| 154 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.93265445 |
| 155 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.92396007 |
| 156 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91746898 |
| 157 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.91177919 |
| 158 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.91137832 |
| 159 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.90992931 |
| 160 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.88707155 |
| 161 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.87609591 |
| 162 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.87381293 |
| 163 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.86612343 |
| 164 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.86027486 |
| 165 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.85980101 |
| 166 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.85852390 |
| 167 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 0.85757664 |
| 168 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.85742409 |
| 169 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.84422841 |
| 170 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.83213580 |
| 171 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.80284747 |
| 172 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.80273982 |
| 173 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79692207 |
| 174 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.78767015 |
| 175 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.78686408 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 3.88837983 |
| 2 | MP0003878_abnormal_ear_physiology | 3.73425696 |
| 3 | MP0005377_hearing/vestibular/ear_phenot | 3.73425696 |
| 4 | MP0005360_urolithiasis | 3.65051947 |
| 5 | MP0006054_spinal_hemorrhage | 3.62756197 |
| 6 | MP0005451_abnormal_body_composition | 3.61502123 |
| 7 | MP0009840_abnormal_foam_cell | 3.58454922 |
| 8 | MP0005365_abnormal_bile_salt | 3.49212929 |
| 9 | MP0009384_cardiac_valve_regurgitation | 2.91976550 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.83085882 |
| 11 | MP0005332_abnormal_amino_acid | 2.81731464 |
| 12 | MP0001849_ear_inflammation | 2.80924939 |
| 13 | MP0002139_abnormal_hepatobiliary_system | 2.46709768 |
| 14 | MP0004885_abnormal_endolymph | 2.42262564 |
| 15 | MP0003279_aneurysm | 2.30795873 |
| 16 | MP0005085_abnormal_gallbladder_physiolo | 2.28490986 |
| 17 | MP0003186_abnormal_redox_activity | 2.23761715 |
| 18 | MP0006036_abnormal_mitochondrial_physio | 2.20215506 |
| 19 | MP0010234_abnormal_vibrissa_follicle | 2.16307060 |
| 20 | MP0003690_abnormal_glial_cell | 2.15865503 |
| 21 | MP0008260_abnormal_autophagy | 2.10686658 |
| 22 | MP0001958_emphysema | 2.10359313 |
| 23 | MP0002249_abnormal_larynx_morphology | 2.08632923 |
| 24 | MP0001764_abnormal_homeostasis | 2.08393310 |
| 25 | MP0003656_abnormal_erythrocyte_physiolo | 2.06371254 |
| 26 | MP0004185_abnormal_adipocyte_glucose | 2.03880140 |
| 27 | MP0004043_abnormal_pH_regulation | 2.02966961 |
| 28 | MP0003566_abnormal_cell_adhesion | 2.02289566 |
| 29 | MP0009697_abnormal_copulation | 2.01634330 |
| 30 | MP0004147_increased_porphyrin_level | 2.01342842 |
| 31 | MP0005083_abnormal_biliary_tract | 1.94217660 |
| 32 | MP0003329_amyloid_beta_deposits | 1.89866324 |
| 33 | MP0003191_abnormal_cellular_cholesterol | 1.89484741 |
| 34 | MP0005257_abnormal_intraocular_pressure | 1.88911610 |
| 35 | MP0005409_darkened_coat_color | 1.88622385 |
| 36 | MP0000678_abnormal_parathyroid_gland | 1.87015289 |
| 37 | MP0005076_abnormal_cell_differentiation | 1.81838996 |
| 38 | MP0005666_abnormal_adipose_tissue | 1.81371405 |
| 39 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.75787364 |
| 40 | MP0009278_abnormal_bone_marrow | 1.72628263 |
| 41 | MP0003453_abnormal_keratinocyte_physiol | 1.69747354 |
| 42 | MP0005058_abnormal_lysosome_morphology | 1.65703298 |
| 43 | MP0001905_abnormal_dopamine_level | 1.61000411 |
| 44 | MP0010368_abnormal_lymphatic_system | 1.58405700 |
| 45 | MP0002837_dystrophic_cardiac_calcinosis | 1.57701244 |
| 46 | MP0010030_abnormal_orbit_morphology | 1.57588407 |
| 47 | MP0001529_abnormal_vocalization | 1.55450349 |
| 48 | MP0004272_abnormal_basement_membrane | 1.53797161 |
| 49 | MP0010329_abnormal_lipoprotein_level | 1.50526756 |
| 50 | MP0004084_abnormal_cardiac_muscle | 1.49581004 |
| 51 | MP0005375_adipose_tissue_phenotype | 1.49041099 |
| 52 | MP0003091_abnormal_cell_migration | 1.47458021 |
| 53 | MP0001502_abnormal_circadian_rhythm | 1.46117001 |
| 54 | MP0003011_delayed_dark_adaptation | 1.44856787 |
| 55 | MP0006138_congestive_heart_failure | 1.44341837 |
| 56 | MP0001661_extended_life_span | 1.44265082 |
| 57 | MP0004233_abnormal_muscle_weight | 1.42576227 |
| 58 | MP0000003_abnormal_adipose_tissue | 1.41306935 |
| 59 | MP0002877_abnormal_melanocyte_morpholog | 1.40542257 |
| 60 | MP0003300_gastrointestinal_ulcer | 1.37343218 |
| 61 | MP0004130_abnormal_muscle_cell | 1.37157175 |
| 62 | MP0000749_muscle_degeneration | 1.37017632 |
| 63 | MP0005670_abnormal_white_adipose | 1.34539953 |
| 64 | MP0005623_abnormal_meninges_morphology | 1.33105071 |
| 65 | MP0000858_altered_metastatic_potential | 1.30874280 |
| 66 | MP0002118_abnormal_lipid_homeostasis | 1.28677616 |
| 67 | MP0003436_decreased_susceptibility_to | 1.28642304 |
| 68 | MP0001348_abnormal_lacrimal_gland | 1.27309165 |
| 69 | MP0001542_abnormal_bone_strength | 1.25880445 |
| 70 | MP0005501_abnormal_skin_physiology | 1.25064254 |
| 71 | MP0002089_abnormal_postnatal_growth/wei | 1.23934372 |
| 72 | MP0000604_amyloidosis | 1.23433063 |
| 73 | MP0000681_abnormal_thyroid_gland | 1.22384584 |
| 74 | MP0000733_abnormal_muscle_development | 1.19304087 |
| 75 | MP0000537_abnormal_urethra_morphology | 1.18974638 |
| 76 | MP0004858_abnormal_nervous_system | 1.18738178 |
| 77 | MP0002796_impaired_skin_barrier | 1.18704385 |
| 78 | MP0001485_abnormal_pinna_reflex | 1.17964472 |
| 79 | MP0003303_peritoneal_inflammation | 1.14403962 |
| 80 | MP0003172_abnormal_lysosome_physiology | 1.14284693 |
| 81 | MP0000759_abnormal_skeletal_muscle | 1.14190743 |
| 82 | MP0005275_abnormal_skin_tensile | 1.13528709 |
| 83 | MP0000920_abnormal_myelination | 1.13416571 |
| 84 | MP0005595_abnormal_vascular_smooth | 1.12428312 |
| 85 | MP0004036_abnormal_muscle_relaxation | 1.11723544 |
| 86 | MP0004215_abnormal_myocardial_fiber | 1.10688391 |
| 87 | MP0003646_muscle_fatigue | 1.10504061 |
| 88 | MP0005023_abnormal_wound_healing | 1.09753647 |
| 89 | MP0005503_abnormal_tendon_morphology | 1.09244323 |
| 90 | MP0000750_abnormal_muscle_regeneration | 1.09237656 |
| 91 | MP0002060_abnormal_skin_morphology | 1.07864631 |
| 92 | MP0005319_abnormal_enzyme/_coenzyme | 1.07684412 |
| 93 | MP0004087_abnormal_muscle_fiber | 1.07143452 |
| 94 | MP0010630_abnormal_cardiac_muscle | 1.05043995 |
| 95 | MP0003122_maternal_imprinting | 1.04683258 |
| 96 | MP0008775_abnormal_heart_ventricle | 1.04523554 |
| 97 | MP0009643_abnormal_urine_homeostasis | 1.04461792 |
| 98 | MP0008438_abnormal_cutaneous_collagen | 1.03809410 |
| 99 | MP0002972_abnormal_cardiac_muscle | 1.03488464 |
| 100 | MP0004947_skin_inflammation | 1.03210734 |
| 101 | MP0000767_abnormal_smooth_muscle | 1.02255880 |
| 102 | MP0003633_abnormal_nervous_system | 1.00909238 |
| 103 | MP0003879_abnormal_hair_cell | 1.00484844 |
| 104 | MP0000609_abnormal_liver_physiology | 0.99958358 |
| 105 | MP0005376_homeostasis/metabolism_phenot | 0.99296775 |
| 106 | MP0005084_abnormal_gallbladder_morpholo | 0.98804391 |
| 107 | MP0003705_abnormal_hypodermis_morpholog | 0.98742766 |
| 108 | MP0001986_abnormal_taste_sensitivity | 0.96364115 |
| 109 | MP0001853_heart_inflammation | 0.93360750 |
| 110 | MP0002896_abnormal_bone_mineralization | 0.93100755 |
| 111 | MP0005330_cardiomyopathy | 0.91283185 |
| 112 | MP0003950_abnormal_plasma_membrane | 0.90646146 |
| 113 | MP0005266_abnormal_metabolism | 0.90313287 |
| 114 | MP0000566_synostosis | 0.90205563 |
| 115 | MP0005508_abnormal_skeleton_morphology | 0.88068544 |
| 116 | MP0003634_abnormal_glial_cell | 0.87931868 |
| 117 | MP0000013_abnormal_adipose_tissue | 0.87671507 |
| 118 | MP0009780_abnormal_chondrocyte_physiolo | 0.87066547 |
| 119 | MP0001666_abnormal_nutrient_absorption | 0.85756648 |
| 120 | MP0002998_abnormal_bone_remodeling | 0.85627643 |
| 121 | MP0004142_abnormal_muscle_tone | 0.85588433 |
| 122 | MP0005636_abnormal_mineral_homeostasis | 0.84887242 |
| 123 | MP0005165_increased_susceptibility_to | 0.84674921 |
| 124 | MP0003075_altered_response_to | 0.84331226 |
| 125 | MP0003183_abnormal_peptide_metabolism | 0.83082852 |
| 126 | MP0002269_muscular_atrophy | 0.83021495 |
| 127 | MP0003195_calcinosis | 0.82692496 |
| 128 | MP0001544_abnormal_cardiovascular_syste | 0.82378633 |
| 129 | MP0005385_cardiovascular_system_phenoty | 0.82378633 |
| 130 | MP0001270_distended_abdomen | 0.81892554 |
| 131 | MP0000230_abnormal_systemic_arterial | 0.80160767 |
| 132 | MP0004859_abnormal_synaptic_plasticity | 0.80090314 |
| 133 | MP0004510_myositis | 0.80028388 |
| 134 | MP0000639_abnormal_adrenal_gland | 0.78604598 |
| 135 | MP0000747_muscle_weakness | 0.78126522 |
| 136 | MP0002971_abnormal_brown_adipose | 0.77893558 |
| 137 | MP0000534_abnormal_ureter_morphology | 0.77310319 |
| 138 | MP0004264_abnormal_extraembryonic_tissu | 0.77253215 |
| 139 | MP0009931_abnormal_skin_appearance | 0.77035812 |
| 140 | MP0005464_abnormal_platelet_physiology | 0.77021482 |
| 141 | MP0008874_decreased_physiological_sensi | 0.76969539 |
| 142 | MP0000467_abnormal_esophagus_morphology | 0.75823392 |
| 143 | MP0006035_abnormal_mitochondrial_morpho | 0.75592600 |
| 144 | MP0000462_abnormal_digestive_system | 0.74919428 |
| 145 | MP0000465_gastrointestinal_hemorrhage | 0.73138735 |
| 146 | MP0003942_abnormal_urinary_system | 0.71396890 |
| 147 | MP0005390_skeleton_phenotype | 0.71016989 |
| 148 | MP0009763_increased_sensitivity_to | 0.70311246 |
| 149 | MP0002132_abnormal_respiratory_system | 0.70208308 |
| 150 | MP0001346_abnormal_lacrimal_gland | 0.70200663 |
| 151 | MP0000598_abnormal_liver_morphology | 0.69363396 |
| 152 | MP0001533_abnormal_skeleton_physiology | 0.68295657 |
| 153 | MP0008469_abnormal_protein_level | 0.68233148 |
| 154 | MP0000343_altered_response_to | 0.67753193 |
| 155 | MP0002638_abnormal_pupillary_reflex | 0.66976180 |
| 156 | MP0005410_abnormal_fertilization | 0.66075941 |
| 157 | MP0000751_myopathy | 0.65548426 |
| 158 | MP0005379_endocrine/exocrine_gland_phen | 0.65543754 |
| 159 | MP0005551_abnormal_eye_electrophysiolog | 0.65441290 |
| 160 | MP0004782_abnormal_surfactant_physiolog | 0.64936899 |
| 161 | MP0009642_abnormal_blood_homeostasis | 0.64807244 |
| 162 | MP0003631_nervous_system_phenotype | 0.64569386 |
| 163 | MP0005621_abnormal_cell_physiology | 0.64486603 |
| 164 | MP0003868_abnormal_feces_composition | 0.64462828 |
| 165 | MP0003252_abnormal_bile_duct | 0.64414680 |
| 166 | MP0001915_intracranial_hemorrhage | 0.61074630 |
| 167 | MP0000477_abnormal_intestine_morphology | 0.60235415 |
| 168 | MP0003115_abnormal_respiratory_system | 0.59718701 |
| 169 | MP0009053_abnormal_anal_canal | 0.58894346 |
| 170 | MP0001614_abnormal_blood_vessel | 0.58497992 |
| 171 | MP0002970_abnormal_white_adipose | 0.58440076 |
| 172 | MP0002933_joint_inflammation | 0.57550860 |
| 173 | MP0002108_abnormal_muscle_morphology | 0.56363467 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Onycholysis (HP:0001806) | 4.56625907 |
| 2 | Protrusio acetabuli (HP:0003179) | 4.06801462 |
| 3 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.93730505 |
| 4 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.82740477 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.78848266 |
| 6 | Abnormality of secondary sexual hair (HP:0009888) | 3.61788229 |
| 7 | Abnormality of the axillary hair (HP:0100134) | 3.61788229 |
| 8 | Neuroendocrine neoplasm (HP:0100634) | 3.48362479 |
| 9 | Biconcave vertebral bodies (HP:0004586) | 3.31133418 |
| 10 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.28578915 |
| 11 | Dicarboxylic aciduria (HP:0003215) | 3.28578915 |
| 12 | Pheochromocytoma (HP:0002666) | 3.27354159 |
| 13 | Hepatic necrosis (HP:0002605) | 3.25326387 |
| 14 | Hyperacusis (HP:0010780) | 3.19385045 |
| 15 | Vertebral compression fractures (HP:0002953) | 3.18229755 |
| 16 | Hypoglycemic coma (HP:0001325) | 3.01156651 |
| 17 | Premature rupture of membranes (HP:0001788) | 2.96553317 |
| 18 | Ulnar bowing (HP:0003031) | 2.94869954 |
| 19 | Cerebral aneurysm (HP:0004944) | 2.91349255 |
| 20 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.89775840 |
| 21 | Abnormality of glycine metabolism (HP:0010895) | 2.89775840 |
| 22 | Hepatocellular necrosis (HP:0001404) | 2.88511478 |
| 23 | Obstructive sleep apnea (HP:0002870) | 2.79720763 |
| 24 | Ketosis (HP:0001946) | 2.76784996 |
| 25 | Increased variability in muscle fiber diameter (HP:0003557) | 2.75610096 |
| 26 | Hyperglycinuria (HP:0003108) | 2.74559048 |
| 27 | Abnormal gallbladder physiology (HP:0012438) | 2.72686497 |
| 28 | Cholecystitis (HP:0001082) | 2.72686497 |
| 29 | Thin bony cortex (HP:0002753) | 2.70587514 |
| 30 | Ketoacidosis (HP:0001993) | 2.68104001 |
| 31 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.67942412 |
| 32 | Hemorrhage of the eye (HP:0011885) | 2.67700061 |
| 33 | Hyperlipoproteinemia (HP:0010980) | 2.65898316 |
| 34 | Distal upper limb amyotrophy (HP:0007149) | 2.64825989 |
| 35 | Upper limb amyotrophy (HP:0009129) | 2.64825989 |
| 36 | Increased serum pyruvate (HP:0003542) | 2.64523765 |
| 37 | Abnormality of glycolysis (HP:0004366) | 2.64523765 |
| 38 | Depressed nasal tip (HP:0000437) | 2.64204201 |
| 39 | Turricephaly (HP:0000262) | 2.63626273 |
| 40 | Generalized aminoaciduria (HP:0002909) | 2.58400335 |
| 41 | Acute necrotizing encephalopathy (HP:0006965) | 2.58199343 |
| 42 | Distal lower limb amyotrophy (HP:0008944) | 2.56917574 |
| 43 | Myopathic facies (HP:0002058) | 2.55216318 |
| 44 | Brittle hair (HP:0002299) | 2.52092834 |
| 45 | Intrahepatic cholestasis (HP:0001406) | 2.51888184 |
| 46 | Methylmalonic aciduria (HP:0012120) | 2.51618274 |
| 47 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.51117875 |
| 48 | Increased connective tissue (HP:0009025) | 2.49975231 |
| 49 | Hyperammonemia (HP:0001987) | 2.49313339 |
| 50 | Cerebral hemorrhage (HP:0001342) | 2.48457217 |
| 51 | Epiphyseal stippling (HP:0010655) | 2.48387403 |
| 52 | Neurofibrillary tangles (HP:0002185) | 2.47881831 |
| 53 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.47527512 |
| 54 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.47527512 |
| 55 | Acute encephalopathy (HP:0006846) | 2.47180351 |
| 56 | Myoglobinuria (HP:0002913) | 2.46923709 |
| 57 | Distal lower limb muscle weakness (HP:0009053) | 2.45704036 |
| 58 | Stridor (HP:0010307) | 2.44412340 |
| 59 | Cervical subluxation (HP:0003308) | 2.42114185 |
| 60 | Hyperbilirubinemia (HP:0002904) | 2.41435281 |
| 61 | Progressive neurologic deterioration (HP:0002344) | 2.40939612 |
| 62 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.40733930 |
| 63 | Achilles tendon contracture (HP:0001771) | 2.39538490 |
| 64 | Neonatal hypoglycemia (HP:0001998) | 2.36769234 |
| 65 | Disproportionate tall stature (HP:0001519) | 2.35615088 |
| 66 | Xanthomatosis (HP:0000991) | 2.33051499 |
| 67 | Abnormality of the umbilical cord (HP:0010881) | 2.31907417 |
| 68 | Exercise-induced myalgia (HP:0003738) | 2.31568616 |
| 69 | Shallow orbits (HP:0000586) | 2.30356552 |
| 70 | Abnormality of nail color (HP:0100643) | 2.30296178 |
| 71 | Mitochondrial inheritance (HP:0001427) | 2.30048394 |
| 72 | Hyperglycinemia (HP:0002154) | 2.29538033 |
| 73 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.29132204 |
| 74 | Opisthotonus (HP:0002179) | 2.28386766 |
| 75 | Mitral regurgitation (HP:0001653) | 2.26527737 |
| 76 | Megaloblastic anemia (HP:0001889) | 2.26041885 |
| 77 | Hypoplastic left heart (HP:0004383) | 2.26035390 |
| 78 | Lactic acidosis (HP:0003128) | 2.25796172 |
| 79 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.25666849 |
| 80 | Fragile skin (HP:0001030) | 2.24908288 |
| 81 | Abnormality of the Achilles tendon (HP:0005109) | 2.24174769 |
| 82 | Chronic otitis media (HP:0000389) | 2.23358216 |
| 83 | Cerebral edema (HP:0002181) | 2.22801168 |
| 84 | Cholelithiasis (HP:0001081) | 2.21512543 |
| 85 | Neoplasm of the adrenal gland (HP:0100631) | 2.20565774 |
| 86 | Brushfield spots (HP:0001088) | 2.20337130 |
| 87 | Spinal rigidity (HP:0003306) | 2.19083451 |
| 88 | Hypobetalipoproteinemia (HP:0003563) | 2.18939264 |
| 89 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.18933529 |
| 90 | Broad face (HP:0000283) | 2.18782611 |
| 91 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.18332737 |
| 92 | Ragged-red muscle fibers (HP:0003200) | 2.16335318 |
| 93 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.16103457 |
| 94 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.16103457 |
| 95 | Mucopolysacchariduria (HP:0008155) | 2.15864588 |
| 96 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.15864588 |
| 97 | Exercise-induced muscle cramps (HP:0003710) | 2.15101028 |
| 98 | Abnormal gallbladder morphology (HP:0012437) | 2.13572666 |
| 99 | Blue sclerae (HP:0000592) | 2.13306551 |
| 100 | Increased CSF lactate (HP:0002490) | 2.13276975 |
| 101 | CNS demyelination (HP:0007305) | 2.13114311 |
| 102 | Late onset (HP:0003584) | 2.12874696 |
| 103 | Insomnia (HP:0100785) | 2.10516971 |
| 104 | Lethargy (HP:0001254) | 2.09896227 |
| 105 | Abnormality of methionine metabolism (HP:0010901) | 2.09042007 |
| 106 | Respiratory failure (HP:0002878) | 2.07747953 |
| 107 | Methylmalonic acidemia (HP:0002912) | 2.07526966 |
| 108 | Asymmetric septal hypertrophy (HP:0001670) | 2.05988577 |
| 109 | Cerebral inclusion bodies (HP:0100314) | 2.05548105 |
| 110 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.05419155 |
| 111 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.05419155 |
| 112 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.05419155 |
| 113 | Vascular tortuosity (HP:0004948) | 2.03425640 |
| 114 | Aneurysm (HP:0002617) | 2.03414434 |
| 115 | Flat acetabular roof (HP:0003180) | 2.03268806 |
| 116 | Bladder diverticulum (HP:0000015) | 2.01205081 |
| 117 | Annular pancreas (HP:0001734) | 2.00909679 |
| 118 | Arterial tortuosity (HP:0005116) | 2.00274436 |
| 119 | Generalized amyotrophy (HP:0003700) | 2.00163061 |
| 120 | Enlarged kidneys (HP:0000105) | 1.97708812 |
| 121 | Hypolipoproteinemia (HP:0010981) | 1.97481682 |
| 122 | Hyperparathyroidism (HP:0000843) | 1.97449154 |
| 123 | Atelectasis (HP:0100750) | 1.95452952 |
| 124 | Abnormality of the thoracic spine (HP:0100711) | 1.94211977 |
| 125 | Hand muscle atrophy (HP:0009130) | 1.94139382 |
| 126 | Steatorrhea (HP:0002570) | 1.93399248 |
| 127 | Joint stiffness (HP:0001387) | 1.92895588 |
| 128 | Metabolic acidosis (HP:0001942) | 1.92458662 |
| 129 | Absent hair (HP:0002298) | 1.92094489 |
| 130 | Easy fatigability (HP:0003388) | 1.91766978 |
| 131 | Increased serum lactate (HP:0002151) | 1.91472791 |
| 132 | Lymphangioma (HP:0100764) | 1.91073199 |
| 133 | Fat malabsorption (HP:0002630) | 1.90309030 |
| 134 | Cerebral palsy (HP:0100021) | 1.90270382 |
| 135 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.90019748 |
| 136 | Hypoglycemic seizures (HP:0002173) | 1.89453313 |
| 137 | Aortic aneurysm (HP:0004942) | 1.88790032 |
| 138 | Hypoalphalipoproteinemia (HP:0003233) | 1.88618864 |
| 139 | Truncus arteriosus (HP:0001660) | 1.88591101 |
| 140 | Premature skin wrinkling (HP:0100678) | 1.87812147 |
| 141 | Increased cerebral lipofuscin (HP:0011813) | 1.87291995 |
| 142 | Broad distal phalanx of finger (HP:0009836) | 1.86971300 |
| 143 | Atrophic scars (HP:0001075) | 1.85978081 |
| 144 | Genu recurvatum (HP:0002816) | 1.85847906 |
| 145 | Cellulitis (HP:0100658) | 1.85022218 |
| 146 | Palpitations (HP:0001962) | 1.84843058 |
| 147 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.84626272 |
| 148 | Sensorimotor neuropathy (HP:0007141) | 1.84507633 |
| 149 | Gout (HP:0001997) | 1.84003045 |
| 150 | Urticaria (HP:0001025) | 1.83950037 |
| 151 | Hyperthyroidism (HP:0000836) | 1.83642040 |
| 152 | Deep venous thrombosis (HP:0002625) | 1.83536950 |
| 153 | Increased muscle lipid content (HP:0009058) | 1.83106169 |
| 154 | Polygenic inheritance (HP:0010982) | 1.82428806 |
| 155 | Wormian bones (HP:0002645) | 1.81848980 |
| 156 | Progressive macrocephaly (HP:0004481) | 1.81001496 |
| 157 | Bulbar palsy (HP:0001283) | 1.79689197 |
| 158 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.79581866 |
| 159 | Aplasia of the phalanges of the hand (HP:0009802) | 1.79581866 |
| 160 | Aplasia involving bones of the extremities (HP:0009825) | 1.79581866 |
| 161 | Dilatation of the ascending aorta (HP:0005111) | 1.79563008 |
| 162 | Reduced antithrombin III activity (HP:0001976) | 1.79185925 |
| 163 | Long palpebral fissure (HP:0000637) | 1.78647507 |
| 164 | Testicular atrophy (HP:0000029) | 1.78458316 |
| 165 | Dysostosis multiplex (HP:0000943) | 1.77633567 |
| 166 | Abnormality of serum amino acid levels (HP:0003112) | 1.77536560 |
| 167 | Axonal loss (HP:0003447) | 1.77415124 |
| 168 | Systemic lupus erythematosus (HP:0002725) | 1.76837709 |
| 169 | Abnormality of the gallbladder (HP:0005264) | 1.76346563 |
| 170 | Supranuclear gaze palsy (HP:0000605) | 1.74083857 |
| 171 | Thin ribs (HP:0000883) | 1.73245931 |
| 172 | Lower limb amyotrophy (HP:0007210) | 1.72236205 |
| 173 | Hypercortisolism (HP:0001578) | 1.71833980 |
| 174 | Ankle clonus (HP:0011448) | 1.71726341 |
| 175 | Broad metatarsal (HP:0001783) | 1.71549921 |
| 176 | Emphysema (HP:0002097) | 1.71201920 |
| 177 | J-shaped sella turcica (HP:0002680) | 1.70466211 |
| 178 | Abnormality of complement system (HP:0005339) | 1.70240053 |
| 179 | Hyperextensible skin (HP:0000974) | 1.69773502 |
| 180 | Hypertensive crisis (HP:0100735) | 1.68846909 |
| 181 | Short nail (HP:0001799) | 1.68725408 |
| 182 | Congenital glaucoma (HP:0001087) | 1.66787016 |
| 183 | Nuclear cataract (HP:0100018) | 1.66436349 |
| 184 | Pointed chin (HP:0000307) | 1.64802696 |
| 185 | Type 1 muscle fiber predominance (HP:0003803) | 1.64794997 |
| 186 | Advanced eruption of teeth (HP:0006288) | 1.64094153 |
| 187 | Difficulty climbing stairs (HP:0003551) | 1.63471681 |
| 188 | Metaphyseal cupping (HP:0003021) | 1.63248834 |
| 189 | Colitis (HP:0002583) | 1.62698170 |
| 190 | Polycythemia (HP:0001901) | 1.62634117 |
| 191 | Eczematoid dermatitis (HP:0000976) | 1.62432998 |
| 192 | Reticulocytosis (HP:0001923) | 1.61594498 |
| 193 | Neuronal loss in central nervous system (HP:0002529) | 1.61199496 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MUSK | 8.42243832 |
| 2 | BCKDK | 4.33432372 |
| 3 | SMG1 | 3.04938534 |
| 4 | TESK2 | 2.89550517 |
| 5 | PDK2 | 2.78005562 |
| 6 | TRIB3 | 2.72970834 |
| 7 | ERN1 | 2.72213958 |
| 8 | EEF2K | 2.52985083 |
| 9 | RIPK1 | 2.48842701 |
| 10 | ICK | 2.46648479 |
| 11 | STK16 | 2.35936629 |
| 12 | PDK4 | 2.23904611 |
| 13 | PDK3 | 2.23904611 |
| 14 | CCNB1 | 2.10359362 |
| 15 | MYLK | 2.09447432 |
| 16 | LMTK2 | 1.94479185 |
| 17 | EPHA2 | 1.86861544 |
| 18 | TIE1 | 1.76855522 |
| 19 | FLT3 | 1.75270687 |
| 20 | PIM2 | 1.67738243 |
| 21 | EIF2AK3 | 1.63779598 |
| 22 | PHKG2 | 1.51582439 |
| 23 | PHKG1 | 1.51582439 |
| 24 | CDK19 | 1.45144605 |
| 25 | NTRK1 | 1.43480622 |
| 26 | MAP3K11 | 1.43089307 |
| 27 | PDGFRA | 1.42134344 |
| 28 | KIT | 1.38686385 |
| 29 | CDK12 | 1.35033939 |
| 30 | MAP3K13 | 1.33927922 |
| 31 | MARK2 | 1.33665210 |
| 32 | KSR2 | 1.32667979 |
| 33 | MAP3K10 | 1.30906421 |
| 34 | ARAF | 1.30238625 |
| 35 | PRKD2 | 1.28940069 |
| 36 | SIK1 | 1.28599094 |
| 37 | LIMK1 | 1.25813304 |
| 38 | CLK1 | 1.25139628 |
| 39 | TNIK | 1.24535892 |
| 40 | PTK6 | 1.22308162 |
| 41 | NME2 | 1.19237229 |
| 42 | ZAP70 | 1.16762134 |
| 43 | TAOK2 | 1.16439182 |
| 44 | CDK8 | 1.12836762 |
| 45 | MAP4K1 | 1.07203738 |
| 46 | CDC42BPA | 1.04601512 |
| 47 | MAP3K3 | 1.04261257 |
| 48 | PTK2 | 1.03727926 |
| 49 | MAP3K1 | 1.03670007 |
| 50 | CSF1R | 1.00921294 |
| 51 | BMPR1B | 1.00531349 |
| 52 | PAK4 | 1.00161068 |
| 53 | TESK1 | 0.99375594 |
| 54 | EIF2AK1 | 0.95356021 |
| 55 | MTOR | 0.95329993 |
| 56 | RPS6KA2 | 0.93819242 |
| 57 | ILK | 0.89744754 |
| 58 | MAP2K3 | 0.89501722 |
| 59 | MST1R | 0.89049863 |
| 60 | PASK | 0.88096733 |
| 61 | BTK | 0.87358581 |
| 62 | FGFR2 | 0.85306927 |
| 63 | WEE1 | 0.84622056 |
| 64 | KDR | 0.82408679 |
| 65 | BMX | 0.82062683 |
| 66 | EPHB2 | 0.81143971 |
| 67 | TYRO3 | 0.78079937 |
| 68 | LRRK2 | 0.77966761 |
| 69 | DDR2 | 0.75499319 |
| 70 | TAOK1 | 0.75493851 |
| 71 | TYK2 | 0.74988857 |
| 72 | MAPK12 | 0.74066151 |
| 73 | MAP2K7 | 0.73475910 |
| 74 | RIPK4 | 0.73223007 |
| 75 | HIPK2 | 0.71522701 |
| 76 | PRPF4B | 0.71506556 |
| 77 | DYRK1B | 0.71352718 |
| 78 | BRAF | 0.70332723 |
| 79 | RET | 0.69831919 |
| 80 | CAMKK1 | 0.67750090 |
| 81 | MAP3K7 | 0.66867102 |
| 82 | NEK6 | 0.65909697 |
| 83 | MAP3K6 | 0.63956745 |
| 84 | TEC | 0.63867788 |
| 85 | MAPK7 | 0.62599406 |
| 86 | CAMK1D | 0.62319991 |
| 87 | TNK2 | 0.62314664 |
| 88 | SIK2 | 0.61260456 |
| 89 | SGK494 | 0.61255019 |
| 90 | SGK223 | 0.61255019 |
| 91 | IRAK3 | 0.60529727 |
| 92 | PTK2B | 0.59125537 |
| 93 | CAMK2G | 0.58630232 |
| 94 | EPHB1 | 0.58468640 |
| 95 | OXSR1 | 0.58450066 |
| 96 | MET | 0.58405404 |
| 97 | PDK1 | 0.55010815 |
| 98 | PIK3CG | 0.53963369 |
| 99 | FGFR4 | 0.52648408 |
| 100 | LATS2 | 0.52539043 |
| 101 | TBK1 | 0.52359276 |
| 102 | PRKACB | 0.52203101 |
| 103 | CAMK2D | 0.51692449 |
| 104 | PINK1 | 0.50871893 |
| 105 | DMPK | 0.49683172 |
| 106 | CAMK1 | 0.49032767 |
| 107 | MOS | 0.48990876 |
| 108 | DAPK3 | 0.48101949 |
| 109 | MAP2K6 | 0.46441093 |
| 110 | VRK1 | 0.46412078 |
| 111 | MAP2K2 | 0.46065095 |
| 112 | SYK | 0.45338350 |
| 113 | PRKCH | 0.45303496 |
| 114 | AKT2 | 0.45236924 |
| 115 | MAP3K8 | 0.44675579 |
| 116 | NEK1 | 0.43557022 |
| 117 | MAPKAPK3 | 0.43089050 |
| 118 | CDK15 | 0.42644299 |
| 119 | SGK2 | 0.42457679 |
| 120 | PRKG2 | 0.42160115 |
| 121 | PRKD1 | 0.41949491 |
| 122 | BUB1 | 0.41886876 |
| 123 | IRAK2 | 0.41689841 |
| 124 | MST4 | 0.41567627 |
| 125 | MAP3K9 | 0.40857592 |
| 126 | CDK18 | 0.40171109 |
| 127 | IRAK4 | 0.39306251 |
| 128 | MAP3K2 | 0.39221284 |
| 129 | MAPK11 | 0.39058298 |
| 130 | CDK4 | 0.39050099 |
| 131 | CDK11A | 0.37760090 |
| 132 | LYN | 0.37673611 |
| 133 | MAPK4 | 0.37534624 |
| 134 | RPS6KL1 | 0.36768370 |
| 135 | RPS6KC1 | 0.36768370 |
| 136 | STK38 | 0.36310918 |
| 137 | PAK2 | 0.35673000 |
| 138 | MAPKAPK5 | 0.35010254 |
| 139 | LATS1 | 0.34733363 |
| 140 | RPS6KA6 | 0.34700732 |
| 141 | BRSK2 | 0.34548516 |
| 142 | MAP3K12 | 0.34479936 |
| 143 | CDK14 | 0.33723239 |
| 144 | TTN | 0.33336204 |
| 145 | MAP2K4 | 0.33104364 |
| 146 | SCYL2 | 0.33054529 |
| 147 | ROCK2 | 0.32931636 |
| 148 | PAK6 | 0.32375662 |
| 149 | INSRR | 0.31816851 |
| 150 | ITK | 0.31428071 |
| 151 | CAMKK2 | 0.30779253 |
| 152 | PDPK1 | 0.30678456 |
| 153 | PRKD3 | 0.30327006 |
| 154 | IGF1R | 0.29836691 |
| 155 | PKN2 | 0.29676151 |
| 156 | CDK7 | 0.29311210 |
| 157 | BLK | 0.29031817 |
| 158 | NEK9 | 0.28765946 |
| 159 | SGK3 | 0.28629561 |
| 160 | MAPK15 | 0.28554536 |
| 161 | STK39 | 0.28486202 |
| 162 | TSSK6 | 0.28156414 |
| 163 | GRK6 | 0.27442129 |
| 164 | NTRK2 | 0.26357463 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.51150185 |
| 2 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.25339158 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.18212791 |
| 4 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.03432764 |
| 5 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.91141762 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.50951639 |
| 7 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.39706015 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.39345462 |
| 9 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.38028613 |
| 10 | Protein export_Homo sapiens_hsa03060 | 2.25190083 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.22203353 |
| 12 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.22184543 |
| 13 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.20203550 |
| 14 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.12410731 |
| 15 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.11687015 |
| 16 | Carbon metabolism_Homo sapiens_hsa01200 | 2.04949288 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.01618041 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 1.98275136 |
| 19 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.96353468 |
| 20 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.95832903 |
| 21 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.89113691 |
| 22 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.85268898 |
| 23 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.82442064 |
| 24 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.76121768 |
| 25 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.70028261 |
| 26 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.68679951 |
| 27 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.67533035 |
| 28 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.64200202 |
| 29 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.63693970 |
| 30 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.62939416 |
| 31 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.56767817 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.56456267 |
| 33 | Prion diseases_Homo sapiens_hsa05020 | 1.53829903 |
| 34 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.53401337 |
| 35 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.50824604 |
| 36 | Bladder cancer_Homo sapiens_hsa05219 | 1.49884375 |
| 37 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.45531844 |
| 38 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.43931983 |
| 39 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.43434854 |
| 40 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.40371920 |
| 41 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.37249363 |
| 42 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.36422954 |
| 43 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.33248775 |
| 44 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.31075494 |
| 45 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.30056422 |
| 46 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.30008475 |
| 47 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.29944249 |
| 48 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.29479650 |
| 49 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.28897107 |
| 50 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.28879847 |
| 51 | Parkinsons disease_Homo sapiens_hsa05012 | 1.27705683 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.24019302 |
| 53 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.23073407 |
| 54 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.21243694 |
| 55 | Endometrial cancer_Homo sapiens_hsa05213 | 1.20518289 |
| 56 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.20328553 |
| 57 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.16424763 |
| 58 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.14576308 |
| 59 | Glioma_Homo sapiens_hsa05214 | 1.13934298 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.13537681 |
| 61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.12498178 |
| 62 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.12240398 |
| 63 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.12051332 |
| 64 | Focal adhesion_Homo sapiens_hsa04510 | 1.10761844 |
| 65 | DNA replication_Homo sapiens_hsa03030 | 1.09967269 |
| 66 | Histidine metabolism_Homo sapiens_hsa00340 | 1.09749443 |
| 67 | Proteasome_Homo sapiens_hsa03050 | 1.08758955 |
| 68 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.07961751 |
| 69 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.05978649 |
| 70 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.05500769 |
| 71 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.04907100 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 1.04284813 |
| 73 | Thyroid cancer_Homo sapiens_hsa05216 | 1.03754304 |
| 74 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.01367733 |
| 75 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.01077187 |
| 76 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.99698825 |
| 77 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.96756694 |
| 78 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.95930155 |
| 79 | Metabolic pathways_Homo sapiens_hsa01100 | 0.95618227 |
| 80 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.94888646 |
| 81 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.94702003 |
| 82 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.94206327 |
| 83 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.92723518 |
| 84 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.92319090 |
| 85 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.91282434 |
| 86 | Amoebiasis_Homo sapiens_hsa05146 | 0.90630262 |
| 87 | Sulfur relay system_Homo sapiens_hsa04122 | 0.90510088 |
| 88 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.90269458 |
| 89 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.89769909 |
| 90 | Insulin resistance_Homo sapiens_hsa04931 | 0.88890123 |
| 91 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.88502267 |
| 92 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.88428907 |
| 93 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.86400328 |
| 94 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.85385284 |
| 95 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.83624871 |
| 96 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.82725592 |
| 97 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.82287647 |
| 98 | Lysosome_Homo sapiens_hsa04142 | 0.81433153 |
| 99 | Hepatitis C_Homo sapiens_hsa05160 | 0.80980822 |
| 100 | Endocytosis_Homo sapiens_hsa04144 | 0.80823936 |
| 101 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.80466790 |
| 102 | ABC transporters_Homo sapiens_hsa02010 | 0.80186897 |
| 103 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.79625189 |
| 104 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.77458608 |
| 105 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.76789522 |
| 106 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.76541860 |
| 107 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.76245264 |
| 108 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.70890768 |
| 109 | Alzheimers disease_Homo sapiens_hsa05010 | 0.70536705 |
| 110 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70119529 |
| 111 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.68361127 |
| 112 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.66800941 |
| 113 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.66119313 |
| 114 | Circadian rhythm_Homo sapiens_hsa04710 | 0.65712608 |
| 115 | Other glycan degradation_Homo sapiens_hsa00511 | 0.65466564 |
| 116 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.65136342 |
| 117 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.65126510 |
| 118 | Long-term potentiation_Homo sapiens_hsa04720 | 0.63913737 |
| 119 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.62399602 |
| 120 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.60820303 |
| 121 | Melanogenesis_Homo sapiens_hsa04916 | 0.59452993 |
| 122 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.58959338 |
| 123 | Colorectal cancer_Homo sapiens_hsa05210 | 0.57824844 |
| 124 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.56021918 |
| 125 | Apoptosis_Homo sapiens_hsa04210 | 0.54239278 |
| 126 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.53873296 |
| 127 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.52434950 |
| 128 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.52433410 |
| 129 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.51646632 |
| 130 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51486271 |
| 131 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.51027211 |
| 132 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.50542361 |
| 133 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.50347429 |
| 134 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.50183989 |
| 135 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.50043099 |
| 136 | Lysine degradation_Homo sapiens_hsa00310 | 0.49843493 |
| 137 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.49301455 |
| 138 | Prostate cancer_Homo sapiens_hsa05215 | 0.49133746 |
| 139 | Retinol metabolism_Homo sapiens_hsa00830 | 0.48093593 |
| 140 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.47533291 |
| 141 | Huntingtons disease_Homo sapiens_hsa05016 | 0.47458722 |
| 142 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47425088 |
| 143 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.47406914 |
| 144 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.46265795 |
| 145 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.46022694 |
| 146 | Bile secretion_Homo sapiens_hsa04976 | 0.46006783 |
| 147 | Hepatitis B_Homo sapiens_hsa05161 | 0.45827149 |
| 148 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.45668099 |
| 149 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.44925930 |
| 150 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44885694 |
| 151 | HTLV-I infection_Homo sapiens_hsa05166 | 0.43744122 |
| 152 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.42619993 |
| 153 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.40293123 |
| 154 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.40103350 |
| 155 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.39660259 |
| 156 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.38306336 |
| 157 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.36943041 |
| 158 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.36071678 |
| 159 | Mismatch repair_Homo sapiens_hsa03430 | 0.35328385 |
| 160 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.35211869 |
| 161 | Purine metabolism_Homo sapiens_hsa00230 | 0.32497072 |
| 162 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.31189803 |
| 163 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.29559373 |
| 164 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.27218755 |
| 165 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.24045306 |
| 166 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.23329254 |
| 167 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.16418898 |
| 168 | Base excision repair_Homo sapiens_hsa03410 | 0.14801154 |
| 169 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.13509985 |

